These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6084134)

  • 1. Effect of guanabenz withdrawal on blood pressure and plasma catecholamines.
    Buckalew VM; Burgess R; Strandhoy JW
    J Cardiovasc Pharmacol; 1984; 6 Suppl 5():S830-2. PubMed ID: 6084134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Withdrawal syndrome following cessation of guanabenz therapy.
    Ram CV; Holland OB; Fairchild C; Gomez-Sanchez CE
    J Clin Pharmacol; 1979; 19(2-3):148-50. PubMed ID: 422739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of plasma catecholamines and blood pressure to clonidine and to sudden withdrawal of the drug in subjects with essential hypertension.
    Planz G; Beckenbauer U; Bundschu HD
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):474-8. PubMed ID: 7141755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of guanabenz in adolescent hypertension.
    Walson PD; Graves P; Rath A; Kilbourne K; Deitch MW
    J Cardiovasc Pharmacol; 1984; 6 Suppl 5():S814-7. PubMed ID: 6084131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of guanabenz on blood pressure responses to posture and exercise.
    Dziedzic SW; Elijovich F; Felton K; Yeager K; Krakoff LR
    Clin Pharmacol Ther; 1983 Feb; 33(2):151-5. PubMed ID: 6337003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guanabenz for adolescent hypertension.
    Walson PD; Rath A; Kilbourne K; Deitch MW
    Pediatr Pharmacol (New York); 1984; 4(1):1-6. PubMed ID: 6739181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guanabenz in essential hypertension.
    McMahon FG; Ryan JR; Jain AK; Vargas R; Vanov SK
    Clin Pharmacol Ther; 1977 Mar; 21(3):272-7. PubMed ID: 319938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure, heart rate, catecholamines and plasma renin activity following institution and withdrawal of guanfacine treatment in moderate hypertension.
    Manhem P; Hökfelt B
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):109S-114S. PubMed ID: 6994763
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of guanabenz and hydrochlorothiazide on blood pressure and plasma renin activity.
    Holland OB; Fairchild C; Gomez-Sanchez CE
    J Clin Pharmacol; 1981 Apr; 21(4):133-9. PubMed ID: 7016928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of guanabenz and clonidine in hypertensive patients.
    Kluyskens Y; Snoeck J
    Curr Med Res Opin; 1980; 6(9):638-43. PubMed ID: 6996935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term antihypertensive therapy with guanfacine.
    Szám I; Holló J
    Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):388-92. PubMed ID: 6749702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of guanabenz and hydrochlorothiazide on plasma lipids.
    Kaplan NM; Grundy S
    Clin Pharmacol Ther; 1988 Sep; 44(3):297-302. PubMed ID: 3046814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive therapy with guanabenz in patients with chronic obstructive pulmonary diseases.
    Deitch MW; Littman GS; Pascucci VL
    J Cardiovasc Pharmacol; 1984; 6 Suppl 5():S818-22. PubMed ID: 6084132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of guanabenz added to hydrochlorothiazide therapy in hypertension.
    Walker BR; Deitch MW; Gold JA; Levey BA
    J Int Med Res; 1982; 10(3):131-9. PubMed ID: 7047256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withdrawal syndrome after guanabenz.
    Walker BR; Geczy M
    J Clin Pharmacol; 1980 Jan; 20(1):69-70. PubMed ID: 7358870
    [No Abstract]   [Full Text] [Related]  

  • 16. Abrupt withdrawal of beta-blocking agents in patients with arterial hypertension. Effect on blood pressure, heart rate and plasma catecholamines and prolactin.
    Lederballe Pedersen O; Mikkelsen E; Lanng Nielsen J; Christensen NJ
    Eur J Clin Pharmacol; 1979 Apr; 15(3):215-7. PubMed ID: 37093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the efficacy and safety of guanabenz versus clonidine.
    Leary WP; Asmal AC; Williams PC
    S Afr Med J; 1979 Jan; 55(3):83-5. PubMed ID: 371036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of guanabenz concentrations in brain and plasma to antihypertensive effect in the spontaneously hypertensive rat.
    Meacham RH; Ruelius HW; Kick CJ; Peters JR; Kocmund SM; Sisenwine SF; Wendt RL
    J Pharmacol Exp Ther; 1980 Sep; 214(3):594-8. PubMed ID: 7400962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response relationship of single oral doses of guanabenz in hypertensive patients.
    Weidler DJ; Garg DC; Jallad NS
    J Cardiovasc Pharmacol; 1984; 6 Suppl 5():S762-5. PubMed ID: 6084121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of placebo versus guanabenz on hypertensive out-patients.
    Walker BR; Schneider BE; Rudnick MR; Gold JA
    J Int Med Res; 1980; 8(5):303-13. PubMed ID: 7418949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.